forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Receptor Agonist Global Market Opportunities And Strategies To 2035 GLP-1 Analogues Market Size, Share

Consistent weekly dosing is essential for maintaining steady-state drug levels and optimal glycaemic control in type 2 diabetes management

Only 5% to 10% have type 1 diabetes, which is caused by a chronic immune attack on the pancreas

Side Effects Comparison Both medications share similar side effect profiles, mainly affecting your digestive system: Nausea (the most common) Vomiting Diarrhea Constipation Stomach pain According to meta-analysis data, adverse events occurred more frequently with retatrutide (risk ratio: 4.10) compared to tirzepatide (risk ratio: 2.78)

This minimal dose reduces early nausea and allows your body to adapt safely before escalation